Finland· FI-REL-REL45624
Obizur
A susoctocog alfa product containing susoctocog alfa, registered in Finland by Baxalta Innovations GmbH. The same ATC class is registered in 11 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Susoctocog alfa is registered in 11 of 19 countries.
Countries holding a registration under ATC B02BD14 (susoctocog alfa), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 7 of them publish a price we can compare per daily dose
Susoctocog alfa · ATC B02BD14
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
Fimea (Finland)- Active substance
- Susoctocog alfa
- Manufacturer
- Baxalta Innovations GmbH
- Country
- Finland (FI)
- ATC code
- B02BD14
- ATC class
- Susoctocog alfa
- Defined daily dose
- 14 TSD, E
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Susoctocog alfa in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaOBIZURBaxalta Innovations GmbH, Vídeň
- SpainOBIZUR 500 U POLVO Y DISOLVENTE PARA SOLUCION INYECTABLEBaxalta Innovations Gmbh
- FranceOBIZUR 500 U, poudre et solvant pour solution injectableBAXALTA INNOVATIONS (AUTRICHE)
- United KingdomObizur 500unit powder and solvent for solution for injection vialsTakeda UK Ltd
- IrelandOBIZUR 500 U powder and solvent for solution for injectionBaxter Innovations GmbH
- IcelandObizurBaxalta Innovations GmbH
- Japanスソクトコグ アルファ（遺伝子組換え）武田薬品工業
- NetherlandsObizur 500 U poeder en oplosmiddel voor oplossing voor injectieBaxter Innovations GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Obizur
- Liechtenstein · Obizur
- Norway · Obizur
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/17952031-2ea7-4f55-b705-00eed858935b GET /v1/drugs/17952031-2ea7-4f55-b705-00eed858935b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "injektiokuiva-aine ja liuotin, liuosta varten",
"route": "Laskimoon",
"ddd_unit": null,
"strength": "500 U",
"atc_label": "susoktokogi alfa",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/15/1035/001-003",
"fimea_rel_id": "REL45624",
"authorised_at": "2015-11-11"
}See everything about susoctocog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.